LASP2 suppresses colorectal cancer progression through JNK/p38 MAPK pathway meditated epithelial-mesenchymal transition

LASP2 suppresses colorectal cancer progression through JNK/p38 MAPK pathway meditated epithelial-mesenchymal transition

Blog Article

Abstract Background LASP2 (LIM and SH3 Protein 2) is a small focal adhesion protein belongs to nebulin protein family.As the newest member of nebulette family, the function of LASP2 remains to be identified.Methods The relationship between LASP2 expression and Gift Card clinical characteristics of CRC was analyzed in 89 paraffin-embedded archived CRC specimens by immunohistochemistry (IHC).The effects of LASP2 on cell growth and migration were examined in vitro, using CCK-8 and transwell assays.Western blotting was performed to examine the impact of LASP2 on the SAPK/JNK and MAPK signaling pathways.

Results In the present study, we observed a decreased LASP2 expression in clinical colorectal cancer samples compared with paired normal tissues.A negative correlation was also found between LASP2 and poor prognosis of CRC patients.Gain- and loss-of-function approaches revealed that LASP2 plays inhibitory effects on the growth and migration of human CRC cells in vitro.Western-blot results showed that LASP2 could attenuate epithelial-mesenchymal transition (EMT) to accomplish its suppression on CRC aggression.In LASP2 knocked down CRC cells, EMT was inhibited along with the inactivation of JNK/p38 MAPK pathway.

Consistently, treatment of JNK inhibitor (JNK inhibitor II) together with p38 inhibitor (SB203580) could resume the process of EMT.Interestingly, we found a negative relationship between LASP2 and LASP1 expression in both CRC cell lines and tumors Pickleball Paddle Cover tissues, which suggests their converse function in CRC progression.Conclusions All the findings indicated that LASP2 may play a significant role in suppressing CRC progression and provided a novel biomarker for CRC therapy.